Alternative Splicing in the Heart: The Therapeutic Potential of Regulating the Regulators
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Francesca Briganti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Alternative Splicing, Myocardium. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Alternative splicing allows a single gene to produce a variety of protein isoforms. Changes in splicing isoform usage characterize virtually every stage of the differentiation process and define the physiological differences between cardiomyocytes with different function, at different stages of development, and pathological function. Recent identification of cardiac splicing factors provided insights into the mechanisms underlying alternative splicing and revealed how these splicing factors impact functional properties of the heart. Alterations of the splicing of sarcomeric genes, cell signaling proteins, and ion channels have been associated with the development of pathological conditions such as cardiomyopathy and arrhythmia. RBM20, RBM24, PTBP1, RBFOX, and QKI play key roles in cardiac development and pathology. A better understanding of their regulation will yield insights into healthy cardiac development and inform the development of molecular therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetics, Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
- Division of Cardiology, Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
ORCID-Profile: Francesca Briganti, Zilu Wang
Förderung
- NHLBI NIH HHS
- National Institute of Health
Zitieren
APA
Briganti, F., & Wang, Z. (2024). Alternative Splicing in the Heart: The Therapeutic Potential of Regulating the Regulators. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313023
Vancouver
Briganti F, Wang Z. Alternative Splicing in the Heart: The Therapeutic Potential of Regulating the Regulators. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313023
BibTeX
@article{Briganti2024,
author = {Briganti, Francesca and Wang, Zilu},
title = {Alternative Splicing in the Heart: The Therapeutic Potential of Regulating the Regulators},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313023}
}
EUVIMED